- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00620360
Acute Effect of Fructose on Lipid Metabolism and Gender Differences
It has been widely documented that fructose overfeeding increases plasma triglycerides and hepatic de novo lipogenesis, and impairs insulin sensitivity in healthy male volunteers. The effect of gender on the metabolic responses to fructose remains an important open question, however.
The objective of this study is to compare the effect of an acute oral fructose load on carbohydrate and lipid metabolism in healthy young males and females.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is aimed at comparing the effects of oral fructose on several specific metabolic pathways in males and females.Participants will receive an isoenergetic diet containing 55% carbohydrate, 15% protein and 35% lipids for three days prior to testing. After this period of controlled diet, they will be studied for 2 hours in the post-absorptive state (Time 0-120 min) and over a 6 hours period (Time 120-480 min) during which they will receive 4 loads of 0,30 g/kg fat free mass U-13C labelled fructose, at times 120, 180, 240, 300. Throughout the study, deuterated glucose and glycerol will be infused to monitor whole body glucose production and glycerol turnover.
The following parameters will be monitored in basal conditions and after the ingestion of the load of fructose:
- Glycerol turnover(glycerol 2H5)
- de novo lipogenesis (incorporation of 13C into palmitate of VLDLs)
- whole body energy expenditure and net substrate oxydation (indirect calorimetry)
- net fructose oxidation (breath 13CO2)
- glucose turnover: (6,6 2H2 Glucose)
- plasma glucose, free fatty acids, ketone bodies, lactate, insulin, triacylglycerol, total cholesterol, VLDL, LDL, and HDL subfractions
An adipose tissue (periumbilical subcutaneous) biopsy will be obtaine by needle aspiration under local anesthesia in fasting conditions (time 0 min) and after fructose (time 480 min) to assess the effects of fructose on adipose gene expression profile. Key genes involved in the regulation of carbohydrate (GLUT 4, hexokinase, PDH-kinase), lipid (FAT-CD36, FABP, acetylCoA carboxylase, malonyl-CoA decarboxylase, PPARg) and energy metabolism (PGC-1a, UCP2)will be monitored
Results obtained in males and females will be compared with two-way analysis of variance
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Vaud
-
Lausanne, Vaud, Switzerland, 1005
- Centre Hospitalier Universitaire Vaudois
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Males and females
- Age 18-35
- Healthy
- Body mass indexes (BMI) between 19 and 25 kg/m2
- Informed consent obtained
Exclusion Criteria:
- Smokers
- Alcohol intake > 30g/day
- Drug abuse
- Diabetes mellitus
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: fructose
acute fructose administration
|
acute administration of 4 times 0.3g fructose/kg lean body mass
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Hepatic de novo lipogenesis
Time Frame: acute effect of dietary fructose (within 6 hours)
|
acute effect of dietary fructose (within 6 hours)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Whole body lipid oxidation, glucose turnover, glycerol turnover, plasma substrates, hormone and energy expenditure (free fatty acid, glucose, lactate, beta-hydroxybutyrate, glycerol, VLDL- Triglycerides and insulin) expression of key adipose genes
Time Frame: acute effect of fructose (within 6 hours)
|
acute effect of fructose (within 6 hours)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 279/07/CE/FBM
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lipid Metabolism
-
Maastricht University Medical CenterRecruitingGlucose Metabolism | Lipid MetabolismNetherlands
-
Université de SherbrookeHospices Civils de LyonCompleted
-
Merck Sharp & Dohme LLCCompletedLipid Metabolism Disorder
-
Mayo ClinicCompleted
-
Northumbria UniversityCompletedLipid MetabolismUnited Kingdom
-
University of JenaCompletedGlucose Metabolism | Lipid Metabolism | SatietyGermany
-
Organon and CoCompleted
-
Luye Pharma Group Ltd.CompletedLipid Metabolism DisorderUnited States
-
Hasselt UniversityRecruitingExercise | Sedentary Behavior | Lipid Metabolism DisorderBelgium
-
University of Texas Southwestern Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingLipid Metabolism DisorderUnited States
Clinical Trials on fructose
-
Rockefeller UniversityThe Rogosin InstituteCompletedCardiovascular Disease | Diabetes | Elevated TriglyceridesUnited States
-
Touro University, CaliforniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingHealthy Participants | Obese But Otherwise Healthy ParticipantsUnited States
-
University of LausanneUniversity of BernCompletedMetabolic SyndromeSwitzerland
-
John SievenpiperCanadian Diabetes Association; The Physicians' Services Incorporated Foundation and other collaboratorsUnknownObesity | Overweight | Body Weight | Adiposity | Obesity, AbdominalCanada
-
University of TorontoCanadian Institutes of Health Research (CIHR); Canadian Diabetes Association; The Physicians' Services Incorporated FoundationUnknownCardiovascular Diseases | Stroke | Hypertension | Diabetes Mellitus, Type 2 | Gout | Metabolic Syndrome XCanada
-
Touro University, CaliforniaActive, not recruitingInsulin Resistance | Insulin Sensitivity | Pre DiabetesUnited States
-
Instituto Nacional de Cardiologia Ignacio ChavezCompletedMetabolic Syndrome | Overweight and Obesity | HyperuricemiaMexico
-
University of CalgaryCompletedChronic Kidney DiseaseCanada
-
Hospital Moinhos de VentoCompleted
-
University of ZurichSwiss National Science FoundationCompleted